Before atomoxetine was approved by the FDA in 2002, all the drugs previously approved for ADHD were stimulants. Stimulants such as amphetamines have the potential to be abused and are sometimes sold illegally.
No, atomoxetine is not classified as a controlled substance. It is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD) and works as a selective norepinephrine reuptake inhibitor. Unlike stimulants commonly used for ADHD, atomoxetine has a lower potential for abuse and dependency, which is why it is not scheduled under the Controlled Substances Act.
Atomoxetine should not be used with certain types of antidepressants known as monoamine oxidase (MAO) inhibitors since this combination may cause blood pressure and heart rates to increase sharply.
Sumatriptan succinate, a medication used to treat migraines, and Strattera (atomoxetine), prescribed for ADHD, can generally be taken together. However, it's important to consult a healthcare provider before combining these medications, as individual health factors and potential interactions may vary. Always follow a doctor's guidance to ensure safety and effectiveness.
No, Strattera (atomoxetine) is not an amphetamine. It is a non-stimulant medication used to treat attention deficit hyperactivity disorder (ADHD) and works by selectively inhibiting the reuptake of norepinephrine in the brain. Unlike amphetamines, which are stimulant medications, Strattera does not have the same potential for abuse or dependence.
Combining Strattera (atomoxetine), a non-stimulant medication used to treat ADHD, with selegiline, a monoamine oxidase inhibitor (MAOI) often used for depression and Parkinson's disease, can pose risks due to potential interactions. While there is limited research on this specific combination, caution is advised, as both medications can influence neurotransmitter levels. It’s essential to consult a healthcare provider to evaluate the potential benefits and risks before using these medications together.
No, Strattera (atomoxetine) is not a monoamine oxidase inhibitor (MAOI). It is a selective norepinephrine reuptake inhibitor (NRI) used primarily to treat attention deficit hyperactivity disorder (ADHD). Unlike MAOIs, which inhibit the enzyme monoamine oxidase and affect multiple neurotransmitters, Strattera specifically targets norepinephrine levels in the brain.
Strattera (atomoxetine) is not classified as a controlled substance. It is a non-stimulant medication used to treat attention deficit hyperactivity disorder (ADHD) and works differently than stimulant medications, which are often controlled due to their potential for abuse. While Strattera is not considered addictive, it should still be used under a healthcare provider's guidance due to potential side effects and interactions.
Librium is the brand name of the prescription drug chlordiazepoxide, which is used to treat anxiety disorders and withdrawal symptoms associated with alcoholism. The medicine is sometimes used in patients to reduce anxiety before a surgical procedure. It's also used to treat symptoms of irritable bowel syndrome.
Clomipramine is used to treat OCD
Sertraline is used to treat OCD
Tetracycline can't be used to treat BV.
Laser have been used to treat BPH. They are not generally used to treat cancer.